New

Asia Pacific Radiopharmaceuticals Market

2021

Asia Pacific Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025878 | No. of Pages: 158 | Category: Pharmaceuticals | Status: Published

Market Insights

Asia Pacific Radiopharmaceuticals Market to Grow at a CAGR of 9.8% to reach US$ 2,661.38 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The APAC radiopharmaceuticals market is expected to grow from US$ 1,384.59 million in 2021 to US$ 2,661.38 million by 2028; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028.


China, India, Japan, South Korea, and Australia are major economies in APAC. Soaring growth in emerging countries is expected to fuel the market growth. Many medical market players focus on emerging countries due to a rise in the prevalence of various diseases in these countries and low per capita income. Further, the prevalence of CVDs is rising significantly in several nations, which can be mainly attributed to the shift in lifestyle as well as the adoption of modern facilities. The modernization of residential, corporate, and commercial facilities is leading to reduction in physical activities, while the stress levels are continuously on the rise due to various factors related to livelihood. These conditions may trigger the possibility of developing CVDs among people, thus boosting the demand for various imaging instruments, including nuclear imaging techniques. Research organizations are engaged in the development of advanced diagnosis systems, including cost-effective and high-performance PET/SPECT systems. These developments are mainly aimed at extending their reach to remote areas where advanced medical IT facilities are not accessible. Emerging countries are spending heavily on the development of PET/SPECT machines to lower their costs as well as to offer hospitals and other medical organizations a better access to these machines. Countries in the region are significant targets for the companies to set up their financial operations and increase revenue generation through strategic planning such as mergers and acquisitions. Thus, several countries are offering significant opportunities to the market players to expand their reach and clientele, which will drive the APAC market in coming years.

In case of COVID-19, APAC is highly affected especially India. The medical practices in the region continue to adapt to the challenges of COVID-19. On the one hand, healthcare professionals are responding to the pandemic, and on the other, it ensures minimal disruption to non-COVID-related procedures and hospitalizations. Hospitals and other healthcare facilities worldwide are forced to postpone elective procedures, such as surgeries. Most non-urgent therapies have been postponed. The COVID-19 pandemic affected health care services in many dimensions, starting from interrupting the regular patient flow to health care facilities, stressing, and overwhelming the health care resources, and leading to the implementation of extra protective measures and social distancing with increased utilization of telehealth and virtual medicine. As a precautionary approach, oncology practices implemented specific measures to reduce the number of patients in outpatient clinics, reduce unnecessary or elective procedures, and discharge patients from inpatient services. This has negatively impacted the growth of the radiopharmaceuticals market in the region. In addition, market players have also been affected by the pandemic owing to supply chain contrarians and reduced demand. The Specialty Pharma segment, especially radiopharma, was impacted due to COVID-19 and competition in radiopharma. Even before the pandemic, Nuclear Medicine’s supply chain was highly complex, depending on the availability of raw materials, manufacturing facilities' operations, and air transportation reliability. Thus, the factors mentioned above are negatively impacting the radiopharmaceuticals market in the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC radiopharmaceuticals market. The APAC radiopharmaceuticals market is expected to grow at a good CAGR during the forecast period.
APAC radiopharmaceuticals market

Get more information on this report :


APAC Radiopharmaceuticals Market Segmentation

APAC Radiopharmaceuticals Market – By Type

  • Diagnostic Nuclear Medicine
    • SPECT
    • PET
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
    • Beta Emitters
    • Brachytherapy Isotopes

APAC Radiopharmaceuticals Market – By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

APAC Radiopharmaceuticals Market – By End User

  • Hospitals
  • Imaging Centers
  • Academic and Research Centers
  • Others

APAC Radiopharmaceuticals Market, by Country

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of APAC

APAC Radiopharmaceuticals Market -Companies Mentioned

  • Advanced Accelerator Applications
  • Bayer AG
  • Bracco Imaging S.p.A
  • Cardinal Health Inc
  • Curium
  • ECZACIBAŞI MONROL NUCLEAR PRODUCTS CO.
  • GENERAL ELECTRIC
  • Lantheus Medical Imaging, Inc.
  • Nordion
  • NTP RADIOISOTOPES

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Radiopharmaceuticals Market – By Type

1.3.2 APAC Radiopharmaceuticals Market – By Application

1.3.3 APAC Radiopharmaceuticals Market – By End User

1.3.4 APAC Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2 Escalating Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Presence of Alternatives

5.3 Market Opportunities

5.3.1 Soaring Growth in Emerging Countries

5.4 Future Trends

5.4.1 Rising Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– APAC Analysis

6.1 APAC Radiopharmaceuticals Market Revenue Forecast and Analysis

7. APAC Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Radiopharmaceuticals Market – Country Analysis

10.1 APAC: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on APAC Radiopharmaceuticals Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Nordion

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 NTP RADIOISOTOPES

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Advanced Accelerator Applications

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of APAC: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Radiopharmaceuticals Market Segmentation

Figure 2. APAC Radiopharmaceuticals Market Segmentation, By Country

Figure 3. APAC Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. APAC Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. APAC Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. APAC SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. APAC Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. APAC Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in APAC Country Markets

  1. Advanced Accelerator Applications
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. Cardinal Health Inc
  5. Curium
  6. ECZACIBAI MONROL NUCLEAR PRODUCTS CO.
  7. GENERAL ELECTRIC
  8. Lantheus Medical Imaging, Inc.
  9. Nordion
  10. NTP RADIOISOTOPES     
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC radiopharmaceuticals market.         
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it 
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025878
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.